PriceTargets.com logo

American Renal Associates - ARA Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$11.52 As of 01/25/2021 01:00 AM ET
+0 (0.00%)
Get New American Renal Associates Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ARA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ARA

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for American Renal Associates in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $11.52.

This chart shows the closing price for ARA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in American Renal Associates. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/11/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/9/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/10/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/8/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/6/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/4/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/4/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/4/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/14/2020BarclaysReiterated RatingHold$7.00Low
5/13/2020SunTrust BanksLower TargetHold$8.00 ➝ $7.00Low
4/13/2020SunTrust BanksLower TargetHold$10.00 ➝ $8.00High
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$12.00High
12/18/2019SunTrust BanksBoost TargetHold$9.00 ➝ $11.00Low
9/10/2019SunTrust BanksBoost TargetPositive ➝ Hold$7.00 ➝ $12.00Medium
(Data available from 5/4/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/7/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/6/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/6/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/5/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/4/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/5/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/4/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/4/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
American Renal Associates logo
American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.
Read More

Today's Range

Now: $11.52
Low: $11.33
High: $11.52

50 Day Range

MA: $11.50
Low: $11.46
High: $11.52

52 Week Range

Now: $11.52
Low: $5.57
High: $11.98

Volume

9,831 shs

Average Volume

106,940 shs

Market Capitalization

$397.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.11

Frequently Asked Questions

What sell-side analysts currently cover shares of American Renal Associates?

The following Wall Street analysts have issued stock ratings on American Renal Associates in the last year:
View the latest analyst ratings for ARA.

What is the current price target for American Renal Associates?

0 Wall Street analysts have set twelve-month price targets for American Renal Associates in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for American Renal Associates in the next year.
View the latest price targets for ARA.

What is the current consensus analyst rating for American Renal Associates?

American Renal Associates currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for ARA.

What other companies compete with American Renal Associates?

Other companies that are similar to American Renal Associates include Entrada Therapeutics, PepGen, Beauty Health, CareDx and OraSure Technologies. Learn More about companies similar to American Renal Associates.

How do I contact American Renal Associates' investor relations team?

American Renal Associates' physical mailing address is 500 CUMMINGS CENTER SUITE 6550, BEVERLY MA, 01915. The company's listed phone number is 978-922-3080 and its investor relations email address is [email protected]. The official website for American Renal Associates is www.americanrenal.com. Learn More about contacing American Renal Associates investor relations.